Unique ID issued by UMIN | UMIN000022938 |
---|---|
Receipt number | R000026436 |
Scientific Title | The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy. |
Date of disclosure of the study information | 2016/06/29 |
Last modified on | 2018/01/16 20:28:19 |
The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.
The study on the antitumor effect of concomitant drug with chemotherapeutic agent for the patients with unresectable pancreatic carcinoma.
The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.
The study on the antitumor effect of concomitant drug with chemotherapeutic agent for the patients with unresectable pancreatic carcinoma.
Japan |
pancreatic carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The aim of this study is to reveal the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.
Efficacy
Progression free survival
Response rate
Disease control rate
Overall survival
Observational
Not applicable |
Not applicable |
Male and Female
The patients with stage 4b pancreatic carcinoma
None
40
1st name | |
Middle name | |
Last name | Yoshiji Hitoshi |
Nara Medical University
Department of Gastroenterology, Endocrinology and Metabolism
840 Shijo-cho, Kashihara, Nara
0744-22-3051
yoshijih@naramed-u.ac.jp
1st name | |
Middle name | |
Last name | Mitoro Akira |
Nara Medical University
Department of Gastroenterology, Endocrinology and Metabolism
840 Shijo-cho, Kashihara, Nara
0744-22-3051
mitoroak@naramed-u.ac.jp
Nara Medical University
None
Self funding
NO
2016 | Year | 06 | Month | 29 | Day |
Unpublished
Enrolling by invitation
2016 | Year | 06 | Month | 20 | Day |
2016 | Year | 06 | Month | 29 | Day |
2022 | Year | 03 | Month | 31 | Day |
we survey the medication for underlying diseases of the patients with stage 4b pancreatic carcinoma. We perform chemotherapy and observe the antitumor effect and prognosis of the patients. We estimate the influence of concomitant drugs on the antitumor effect of the chemotherapy and prognosis of subjects.
2016 | Year | 06 | Month | 29 | Day |
2018 | Year | 01 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026436
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |